A small trial of Alpha DaRT from Israel’s Alpha Tau (see here previously) was 100% successful in treating 10 patients with skin cancer. All were 100% clear at 12 weeks with no recurrence or toxicities in 24 weeks.

https://www.globenewswire.com/news-release/2023/05/11/2667240/0/en/Alpha-Tau-Announces-the-Publication-of-its-US-Multicenter-Pilot-Skin-Cancer-Trial-Results-in-JAMA-Network-Open.html

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804784